Contact Us
Find A Doctor

Exudative Age-Related Macular Degeneration

Principal Investigator

Richard Rosen, MD

Enrollment Status:

Closed to Enrollment


To evaluate the efficacy of intravitreal bevasiranib sodium as maintenance therapy for Age-Related Macular Degeneration following initiation of anti-VEGF therapy with 3 doses of Lucentis®




Contact Us

Dr. Richard Rosen, Principal InvestigatorTel: (212) 979-4284

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locations